Cargando…

Minimum Data Set for Cystic Fibrosis Registry: a Case Study in Iran

BACKGROUND: over the last 25 years several national registries of CF have been set up. Such systems can be very useful in providing an integrated resource for improving patient care and conducting research on the disease. Minimum Data Set is a common set of data items that should be used to collect...

Descripción completa

Detalles Bibliográficos
Autores principales: Kalankesh, Leila R, Dastgiri, Saeed, Rafeey, Mandana, Rasouli, Narmin, Vahedi, Leila
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AVICENA, d.o.o., Sarajevo 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4384873/
https://www.ncbi.nlm.nih.gov/pubmed/25870486
http://dx.doi.org/10.5455/aim.2015.23.18-21
_version_ 1782364973345800192
author Kalankesh, Leila R
Dastgiri, Saeed
Rafeey, Mandana
Rasouli, Narmin
Vahedi, Leila
author_facet Kalankesh, Leila R
Dastgiri, Saeed
Rafeey, Mandana
Rasouli, Narmin
Vahedi, Leila
author_sort Kalankesh, Leila R
collection PubMed
description BACKGROUND: over the last 25 years several national registries of CF have been set up. Such systems can be very useful in providing an integrated resource for improving patient care and conducting research on the disease. Minimum Data Set is a common set of data items that should be used to collect and report data in the registry. The principal aim of this research was to determine minimum data set for the CF registry in north-west of Iran. METHODS: data items collected by several selected registries of cystic fibrosis were studied and an initial set of data was selected by the researchers. A group of experts including epidemiologists, pediatricians, and CF specialists were asked to review the proposed data elements and score them based on their importance by using a nine-point Likert scale. The items scored as important or highly important by more than 50 % of the experts, were included in final list of minimum data set. Availability of data was evaluated through reviewing medical records of 144 patients hospitalized in Children Hospital located in Tabriz. RESULTS: overall six classes of data (46 items) were identified in the selected registry systems for cystic fibrosis: patient demographics, administrative data, survival status, diagnostic procedures, genetic and clinical manifestations, and therapeutics. Thirty two data elements from all six categories of data were approved by the experts as the minimum data set for cystic fibrosis registry system. Availability of data in administrative category and survival class was 100 percent. Collecting data on medications was feasible in 100% of the cases as well. In class of demographic data, accessibility of patient name, age, gender, place of birth, and date of birth was 100 percent. In group of diagnostic procedures, partial availability of data was found for sweat test and genetic test. No data was found on the antenatal screening, exercise tolerance test, and glucose tolerance test. CONCLUSION: this work can be considered as a first step toward establishing CF registry system in Iran. Minimum data set can be also useful in designing electronic registry or electronic patient records for those suffering from CF toward integration of their fragmented records across continuum of the health care system in order to improve quality of shared patient care.
format Online
Article
Text
id pubmed-4384873
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher AVICENA, d.o.o., Sarajevo
record_format MEDLINE/PubMed
spelling pubmed-43848732015-04-13 Minimum Data Set for Cystic Fibrosis Registry: a Case Study in Iran Kalankesh, Leila R Dastgiri, Saeed Rafeey, Mandana Rasouli, Narmin Vahedi, Leila Acta Inform Med Original Paper BACKGROUND: over the last 25 years several national registries of CF have been set up. Such systems can be very useful in providing an integrated resource for improving patient care and conducting research on the disease. Minimum Data Set is a common set of data items that should be used to collect and report data in the registry. The principal aim of this research was to determine minimum data set for the CF registry in north-west of Iran. METHODS: data items collected by several selected registries of cystic fibrosis were studied and an initial set of data was selected by the researchers. A group of experts including epidemiologists, pediatricians, and CF specialists were asked to review the proposed data elements and score them based on their importance by using a nine-point Likert scale. The items scored as important or highly important by more than 50 % of the experts, were included in final list of minimum data set. Availability of data was evaluated through reviewing medical records of 144 patients hospitalized in Children Hospital located in Tabriz. RESULTS: overall six classes of data (46 items) were identified in the selected registry systems for cystic fibrosis: patient demographics, administrative data, survival status, diagnostic procedures, genetic and clinical manifestations, and therapeutics. Thirty two data elements from all six categories of data were approved by the experts as the minimum data set for cystic fibrosis registry system. Availability of data in administrative category and survival class was 100 percent. Collecting data on medications was feasible in 100% of the cases as well. In class of demographic data, accessibility of patient name, age, gender, place of birth, and date of birth was 100 percent. In group of diagnostic procedures, partial availability of data was found for sweat test and genetic test. No data was found on the antenatal screening, exercise tolerance test, and glucose tolerance test. CONCLUSION: this work can be considered as a first step toward establishing CF registry system in Iran. Minimum data set can be also useful in designing electronic registry or electronic patient records for those suffering from CF toward integration of their fragmented records across continuum of the health care system in order to improve quality of shared patient care. AVICENA, d.o.o., Sarajevo 2015-02 2015-02-22 /pmc/articles/PMC4384873/ /pubmed/25870486 http://dx.doi.org/10.5455/aim.2015.23.18-21 Text en Copyright: © Leila R Kalankesh, Saeed Dastgiri, Mandana Rafeey, Narmin Rasouli, Leila Vahedi http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Paper
Kalankesh, Leila R
Dastgiri, Saeed
Rafeey, Mandana
Rasouli, Narmin
Vahedi, Leila
Minimum Data Set for Cystic Fibrosis Registry: a Case Study in Iran
title Minimum Data Set for Cystic Fibrosis Registry: a Case Study in Iran
title_full Minimum Data Set for Cystic Fibrosis Registry: a Case Study in Iran
title_fullStr Minimum Data Set for Cystic Fibrosis Registry: a Case Study in Iran
title_full_unstemmed Minimum Data Set for Cystic Fibrosis Registry: a Case Study in Iran
title_short Minimum Data Set for Cystic Fibrosis Registry: a Case Study in Iran
title_sort minimum data set for cystic fibrosis registry: a case study in iran
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4384873/
https://www.ncbi.nlm.nih.gov/pubmed/25870486
http://dx.doi.org/10.5455/aim.2015.23.18-21
work_keys_str_mv AT kalankeshleilar minimumdatasetforcysticfibrosisregistryacasestudyiniran
AT dastgirisaeed minimumdatasetforcysticfibrosisregistryacasestudyiniran
AT rafeeymandana minimumdatasetforcysticfibrosisregistryacasestudyiniran
AT rasoulinarmin minimumdatasetforcysticfibrosisregistryacasestudyiniran
AT vahedileila minimumdatasetforcysticfibrosisregistryacasestudyiniran